Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

Tecan Journal dot

Selected category: Tecan D300e Digital Dispenser

Back to overview

Automation dispenses with time-consuming calculations and preparation

Automation brings more than simply speed to the laboratory. Modern software is taking the headache out of serial dilution and normalization calculations, supporting assay development and delivering reliable results for international healthcare company Merck.

Read more

Working towards cancer-free childhoods

Developing cancer drugs for clinical trials involves not only identifying and evaluating suitable agents, but also observing how they interact with the cocktail of other drugs in a cancer treatment regime. For the Telethon Kids Cancer Centre in Perth, Western Australia, increasing throughput and reducing assay volumes are essential to save money and time in the race to beat cancer.

Read more

Traditional medicine meets modern analytics

Chinese medicine combines herbal remedies with acupuncture, massage, exercise and diet to provide alternative therapies for a wide range of conditions. Despite drawing on over 2,500 years of traditional knowledge, little is known about the mode of action of these herbal medicines. Researchers at Zhejiang University’s College of Pharmaceutical Sciences are looking to address this, using modern laboratory techniques to identify the numerous active pharmaceutical ingredients and synergistic effects that contribute to their efficacy.

Read more

Taking the guesswork out of drug development

California-based company zPREDICTA™ has created a novel technology that reconstructs physiologically-relevant organ-specific human microenvironments that help eliminate the guesswork from drug development. Meaningful drug discovery studies involve complex experiments that are not feasible to perform manually. Automation is the answer, improving accuracy, saving time and reducing the amount of compound used.

Read more

Lighter work for many hands

Drug development pipelines are under ever-increasing pressure to deliver more comprehensive data in a shorter timeframe, while reducing costs and making in vitro assay results more relevant to in vivo drug behavior. Assay automation and miniaturization has become essential for the oncology research team in Bayer’s Pharmaceuticals Division.

Read more